» Articles » PMID: 20943986

Suppression of Innate Immune Pathology by Regulatory T Cells During Influenza A Virus Infection of Immunodeficient Mice

Overview
Journal J Virol
Date 2010 Oct 15
PMID 20943986
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

The viral infection of higher vertebrates elicits potent innate and adaptive host immunity. However, an excessive or inappropriate immune response also may lead to host pathology that often is more severe than the direct effects of viral replication. Therefore, several mechanisms exist that regulate the magnitude and class of the immune response. Here, we have examined the potential involvement of regulatory T (Treg) cells in limiting pathology induced by influenza A virus (IAV) infection. Using lymphocyte-deficient mice as hosts, we showed that Treg cell reconstitution resulted in a significant delay in weight loss and prolonged survival following infection. The adoptively transferred Treg cells did not affect the high rate of IAV replication in the lungs of lymphocyte-deficient hosts, and therefore their disease-ameliorating effect was mediated through the suppression of innate immune pathology. Mechanistically, Treg cells reduced the accumulation and altered the distribution of monocytes/macrophages in the lungs of IAV-infected hosts. This reduction in lung monocytosis was associated with a specific delay in monocyte chemotactic protein-2 (MCP-2) induction in the infected lungs. Nevertheless, Treg cells failed to prevent the eventual development of severe disease in lymphocyte-deficient hosts, which likely was caused by the ongoing IAV replication. Indeed, using T-cell-deficient mice, which mounted a T-cell-independent B cell response to IAV, we further showed that the combination of virus-neutralizing antibodies and transferred Treg cells led to the complete prevention of clinical disease following IAV infection. Taken together, these results suggested that innate immune pathology and virus-induced pathology are the two main contributors to pathogenesis during IAV infection.

Citing Articles

MEK-inhibitor treatment reduces the induction of regulatory T cells in mice after influenza A virus infection.

Koch-Heier J, Vogel A, Full Y, Ebensperger M, Schonsiegel A, Zinser R Front Immunol. 2024; 15:1360698.

PMID: 38979428 PMC: 11228811. DOI: 10.3389/fimmu.2024.1360698.


Runx3 Regulates CD8 T Cell Local Expansion and CD43 Glycosylation in Mice by H1N1 Influenza A Virus Infection.

Hao Q, Kundu S, Shetty S, Tang H Int J Mol Sci. 2024; 25(8).

PMID: 38673806 PMC: 11050410. DOI: 10.3390/ijms25084220.


Ex Pluribus Unum: The CD4 T Cell Response against Influenza A Virus.

Finn C, McKinstry K Cells. 2024; 13(7.

PMID: 38607077 PMC: 11012043. DOI: 10.3390/cells13070639.


A Review on Role of Inflammation in Coronavirus Disease.

Lotfi A, Hajian P, Abbasi L, Gargari M, Fard N, Naderi D Endocr Metab Immune Disord Drug Targets. 2024; 24(13):1488-1505.

PMID: 38303532 DOI: 10.2174/0118715303265274231204075802.


Regulatory T cell-derived IL-1Ra suppresses the innate response to respiratory viral infection.

Griffith J, Faustino L, Cottrell V, Nepal K, Hariri L, Chiu R Nat Immunol. 2023; 24(12):2091-2107.

PMID: 37945820 PMC: 11887468. DOI: 10.1038/s41590-023-01655-2.


References
1.
Moskophidis D, Kioussis D . Contribution of virus-specific CD8+ cytotoxic T cells to virus clearance or pathologic manifestations of influenza virus infection in a T cell receptor transgenic mouse model. J Exp Med. 1998; 188(2):223-32. PMC: 2212460. DOI: 10.1084/jem.188.2.223. View

2.
Struyf S, Van Collie E, Paemen L, Put W, Lenaerts J, Proost P . Synergistic induction of MCP-1 and -2 by IL-1beta and interferons in fibroblasts and epithelial cells. J Leukoc Biol. 1998; 63(3):364-72. DOI: 10.1002/jlb.63.3.364. View

3.
Taubenberger J, Morens D . The pathology of influenza virus infections. Annu Rev Pathol. 2007; 3:499-522. PMC: 2504709. DOI: 10.1146/annurev.pathmechdis.3.121806.154316. View

4.
Muller G, Hopken U, Lipp M . The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity. Immunol Rev. 2003; 195:117-35. DOI: 10.1034/j.1600-065x.2003.00073.x. View

5.
Shevach E . Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity. 2009; 30(5):636-45. DOI: 10.1016/j.immuni.2009.04.010. View